Autologous fibroblasts induce fibrosis of the nucleus pulposus to maintain the stability of degenerative intervertebral discs

Abstract

Lumbar degenerative disc diseases cause low back pain (LBP). The maintenance of the height and stability of the intervertebral disc (IVD) space is an effective treatment for LBP. The following study evaluated the effects of fibroblast injection on intervertebral disc degeneration (IDD) in a preclinical setting. Compared with the IDD group, the fibroblast treatment group demonstrated effective maintenance of IVD height, reduced endplate degeneration, and improved nuclear magnetic resonance signals and overall histological structure. In doing so, fibrotic IVDs maintained the stability and biomechanics of the vertebra. This finding is in agreement with clinical findings that human nucleus pulposus (NP) fibrosis is essential for the maintenance of IVD height and mechanical properties in patients following percutaneous endoscopic lumbar discectomy (PELD). Mechanistically, we demonstrated that injected fibroblasts not only proliferated but also induced NP cells to adopt a fibrotic phenotype via the secretion of TGF-β. Finally, to better mimic human conditions, the efficacy of autologous fibroblast injection in the treatment of IDD was further examined in a nonhuman primate cynomolgus monkey model due to their capacity for upright posture. We showed that the injection of fibroblasts could maintain the IVD height and rescue IVD signals in cynomolgus monkeys. Taken together, the results of our study reveal that autologous fibroblast injection can enhance the natural process of fibrosis during acute and subacute stages of stress-induced IDD. Fibrotic IVDs can maintain the stability, biological activity, and mechanical properties of the intervertebral space, thus providing a new direction for the treatment of intervertebral space-derived lumbar degenerative diseases.

References

[1] Hill P. Low back pain. N. Engl. J. Med., 2001, 344:1644 author reply 1644–1645

[2] Meyer MA. Persistent low back pain. N. Engl. J. Med., 2005, 353:956-957

[3] Wilkens P, Scheel IB, Grundnes O, Hellum C, Storheim K. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial. JAMA, 2010, 304:45-52

[4] Wang X, Wanyan P, Tian J, Hu L. Meta-analysis of randomized trials comparing fusion surgery to non-surgical treatment for discogenic chronic low back pain. J. Back Musculoskelet. Rehabil., 2015, 28:621-627

[5] Panagiotacopulos ND, Knauss WG, Bloch R. On the mechanical properties of human intervertebral disc material. Biorheology, 1979, 16:317-330

[6] Bydon M et al. Lumbar fusion versus nonoperative management for treatment of discogenic low back pain: a systematic review and meta-analysis of randomized controlled trials. J. Spinal Disord. Tech., 2014, 27:297-304

[7] Sun Y et al. Comparison of adjacent segment degeneration five years after single level cervical fusion and cervical arthroplasty: a retrospective controlled study. Chin. Med. J. (Engl.), 2012, 125:3939-3941

[8] Ziv I, Moskowitz RW, Kraise I, Adler JH, Maroudas A. Physicochemical properties of the aging and diabetic sand rat intervertebral disc. J. Orthop. Res., 1992, 10:205-210

[9] Nerlich AG, Boos N, Wiest I, Aebi M. Immunolocalization of major interstitial collagen types in human lumbar intervertebral discs of various ages. Virchows Arch., 1998, 432:67-76

[10] Teichtahl AJ et al. A Dose-response relationship between severity of disc degeneration and intervertebral disc height in the lumbosacral spine. Arthritis Res. Ther., 2015, 17:297

[11] Frahs S et al. Extracellular Matrix Expression and Production in Fibroblast-Collagen Gels: Towards an In Vitro Model for Ligament Wound Healing. Ann. Biomed. Eng., 2018, 46:1882-1895

[12] Specchia N, Pagnotta A, Toesca A, Greco F. Cytokines and growth factors in the protruded intervertebral disc of the lumbar spine. Eur. Spine J., 2002, 11:145-151

[13] Xu X et al. Transforming growth factor-β in stem cells and tissue homeostasis. Bone Res., 2018, 6:2

[14] Chee Ana et al. Cell therapy with human dermal fibroblasts enhances intervertebral disk repair and decreases inflammation in the rabbit model. Glob. Spine J., 2016, 6 Dec 771-779

[15] Shi P et al. Therapeutic effects of cell therapy with neonatal human dermal fibroblasts and rabbit dermal fibroblasts ondisc degeneration and inflammation. Spine J., 2019, 19 Jan 171-181

[16] Han B et al. A simple disc degeneration model induced by percutaneous needle puncture in the rat tail. Spine, 2008, 33:1925-1934

[17] Walter BA et al. MR elastography-derived stiffness: a biomarker for intervertebral disc degeneration. Radiology, 2017, 285:167-175

[18] Stolworthy DK et al. MRI evaluation of spontaneous intervertebral disc degeneration in the alpaca cervical spine. J. Orthop. Res., 2015, 33:1776-1783

[19] Ohnishi T et al. In Vivo Mouse Intervertebral Disc Degeneration Model Based on a New Histological Classification. PLoS One, 2016, 11

[20] Millecamps M, Czerminski JT, Mathieu AP, Stone LS. Behavioral signs of axial low back pain and motor impairment correlate with the severity of intervertebral disc degeneration in a mouse model. Spine J., 2015, 15:2524-2537

[21] Lv F et al. In search of nucleus pulposus-specific molecular markers. Rheumatol. (Oxf.), 2014, 53:600-610

[22] Strutz F et al. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol., 1995, 130:393-405

[23] Sun L et al. FSP1(+) fibroblast subpopulation is essential for the maintenance and regeneration of medullary thymic epithelial cells. Sci. Rep., 2015, 5

[24] Bian Q et al. Mechanosignaling activation of TGFβ maintains intervertebral disc homeostasis. Bone Res., 2017, 5 Mar 17008

[25] Stewart A, Thomas B, Koff J. TGF-β: Master regulator of inflammation and fibrosis. Respirology, 2018, 23 Dec 1096-1097

[26] Perez-Cruet M et al. Potential of human nucleus pulposus-like cells derived from umbilical cord to treat degenerative disc disease. Neurosurgery, 2018, 84 Jan 272-283

[27] Henry N, Clouet J, Le Bideau J, Le Visage C, Guicheux J. Innovative strategies for intervertebral disc regenerative medicine: from cell therapies to multiscale delivery systems. Biotechnol. Adv., 2018, 36:281-294

[28] Xie Z et al. TGF-β synergizes with ML264 to block IL-1β-induced matrix degradation mediated by Krüppel-like factor 5 in the nucleus pulposus. Biochim Biophys. Acta Mol. Basis Dis., 2018, 1864:579-589

[29] Zhang J et al. TGF-β1 suppresses CCL3/4 expression through the ERK signaling pathway and inhibits intervertebral disc degeneration and inflammation-related pain in a rat model. Exp. Mol. Med., 2017, 49

[30] Yang H et al. TGF-βl suppresses inflammation in cell therapy for intervertebral disc degeneration. Sci. Rep., 2015, 5

[31] Wen X et al. LOXL2, a copper-dependent monoamine oxidase, activates lung fibroblasts through the TGF-β/Smad pathway. Int J. Mol. Med., 2018, 42:3530-3541

[32] Yoshida K, Murata M, Yamaguchi T, Matsuzaki K. TGF-beta/Smad signaling during hepatic fibro-carcinogenesis (review). Int J. Oncol., 2014, 45:1363-1371

[33] Chen L et al. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment. Biomed. Pharmacother., 2018, 101 May 670-681

[34] Eser PO, Janne PA. TGFβ pathway inhibition in the treatment of non-small cell lung cancer. Pharmacol. Ther., 2018, 184 Apr 112-130

[35] Loboda A, Sobczak M, Jozkowicz A, Dulak J. TGF-β1/Smads and miR-21 in renal fibrosis and inflammation. Mediators Inflamm., 2016, 2016:8319283

[36] Higgins SP et al. TGF-β1/p53 signaling in renal fibrogenesis. Cell signal., 2018, 43 Mar 1-10

[37] Yang L et al. Taurine reduced epidural fibrosis in rat models after laminectomy via downregulating EGR1. Cell Physiol. Biochem, 2016, 38:2261-2271

[38] Rinkevich Y et al. Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science, 2015, 348:aaa2151

[39] Boos N et al. Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine, 2002, 27:2631-2644

[40] Rutges J et al. Micro-CT quantification of subchondral endplate changes in intervertebral disc degeneration. Osteoarthr. Cartil., 2011, 19:89-95

Funding

National Natural Science Foundation of China (National Science Foundation of China)(81871790)

Shanghai Hospital Development Center (SHDC)(SHDC12016110)